{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:48Z","timestamp":1761894768378},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.3816\/clm.2005.n.036","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:28Z","timestamp":1221095428000},"page":"102-114","source":"Crossref","is-referenced-by-count":37,"title":["Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.3816","volume":"6","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2005.n.036_bib1","first-page":"211","article-title":"Studies on conditions associated with disturbed gamma globulin formation (gammopathies)","volume":"56","author":"Waldenstrom","year":"1960","journal-title":"Harvey Lect"},{"key":"10.3816\/CLM.2005.n.036_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance. Natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) om 6,995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"key":"10.3816\/CLM.2005.n.036_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle","year":"1972","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finistere, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Pathol"},{"key":"10.3816\/CLM.2005.n.036_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9343(87)90375-5","article-title":"Evaluation of monoclonal gammopathies in the \u201cwell\u201d elderly","volume":"82","author":"Crawford","year":"1987","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly [published erratum in Am J Med 1998; 105:362]","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib8","first-page":"785","article-title":"Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting","volume":"116","author":"Singh","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.3816\/CLM.2005.n.036_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1532-5415.1993.tb05940.x","article-title":"A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly [published erratum in J Am Geriatr Soc 1993; 41:622]","volume":"41","author":"Bowden","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"10.3816\/CLM.2005.n.036_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1098-2825(2000)14:2<64::AID-JCLA5>3.0.CO;2-O","article-title":"Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis","volume":"14","author":"Kurihara","year":"2000","journal-title":"J Clin Lab Anal"},{"key":"10.3816\/CLM.2005.n.036_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1468-0734.2002.00076.x","article-title":"Monoclonal gammopathies of undetermined significance","volume":"6","author":"Kyle","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"10.3816\/CLM.2005.n.036_bib12","series-title":"Manual of Clinical Laboratory Immunology","first-page":"71","article-title":"Immunochemical characterization of immunoglobulins","author":"Kyle","year":"2002"},{"key":"10.3816\/CLM.2005.n.036_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5858\/1999-123-0114-SOTFMG","article-title":"Sequence of testing for monoclonal gammopathies","volume":"123","author":"Kyle","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.3816\/CLM.2005.n.036_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5858\/1999-123-0106-GFCALE","article-title":"Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies","volume":"123","author":"Keren","year":"1999","journal-title":"Arch Pathol Lab Med"},{"issue":"pt 3","key":"10.3816\/CLM.2005.n.036_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000456329102800310","article-title":"Overestimation of monoclonal immunoglobulin by immunochemical methods","volume":"28","author":"Riches","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"10.3816\/CLM.2005.n.036_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"10.3816\/CLM.2005.n.036_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1373\/clinchem.2004.046870","article-title":"Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice","volume":"51","author":"Katzmann","year":"2005","journal-title":"Clin Chem"},{"key":"10.3816\/CLM.2005.n.036_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CLM.2005.n.036_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.036_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CLM.2005.n.036_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.0954-6820.1986.tb03349.x","article-title":"A 20-year follow-up study of 64 subjects with M-components","volume":"219","author":"Axelsson","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.3816\/CLM.2005.n.036_bib22","first-page":"123","article-title":"Idiopathic monoclonal gammopathy. Long-term study of 313 cases","volume":"80","author":"Paladini","year":"1989","journal-title":"Recenti Prog Med"},{"key":"10.3816\/CLM.2005.n.036_bib23","first-page":"377","article-title":"Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases","volume":"36","author":"Giraldo","year":"1991","journal-title":"Sangre (Barc)"},{"key":"10.3816\/CLM.2005.n.036_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.1995.tb05256.x","article-title":"Malignant transformation of monoclonal gammopathy of undetermined significance among outpatients of a community hospital in southeastern Netherlands","volume":"91","author":"van de Poel","year":"1995","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy","volume":"87","author":"Baldini","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000203676","article-title":"The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow- up of 263 cases","volume":"97","author":"Pasqualetti","year":"1997","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2001.02533.x","article-title":"Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance","volume":"112","author":"Gregersen","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M","article-title":"Cancer risk in patients with monoclonal gammopathy of undetermined significance","volume":"63","author":"Gregersen","year":"2000","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2005.n.036_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10428190109099321","article-title":"Malignant transformation of monoclonal gammopathy of undetermined significance: cumulative incidence and prognostic factors","volume":"42","author":"Van De Donk","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2005.n.036_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2002.03589.x","article-title":"Monoclonal gammopathy in Iceland: a population-based registry and follow-up","volume":"118","author":"Ogmundsdottir","year":"2002","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.036_bib33","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2005.n.036_bib34","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2005.n.036_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib36","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome","volume":"94","author":"Avet-Loiseau","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib38","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma","volume":"6","author":"Rajkumar","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2005.n.036_bib39","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2005.n.036_bib40","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CLM.2005.n.036_bib43","series-title":"Hematology 2002: American Society of Hematology Education Program Book","first-page":"227","article-title":"Biology of myeloma bone disease","author":"Roodman","year":"2002"},{"key":"10.3816\/CLM.2005.n.036_bib44","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1182\/blood.V98.13.3534","article-title":"Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma","volume":"98","author":"Croucher","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0889-8588(05)70115-5","article-title":"The role of interleukin-1 beta in the pathogenesis of multiple myeloma","volume":"13","author":"Lust","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2005.n.036_bib46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2002.05668.x","article-title":"Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance","volume":"97","author":"Malik","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.3816\/CLM.2005.n.036_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2141.2002.03912.x","article-title":"Helicobacter pylori infection and monoclonal gammopathy of undetermined significance","volume":"119","author":"Rajkumar","year":"2002","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2003.00056.x","article-title":"Monoclonal gammopathies of undetermined signficance: a review","volume":"194","author":"Kyle","year":"2003","journal-title":"Immunol Rev"},{"key":"10.3816\/CLM.2005.n.036_bib49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2004.05169.x","article-title":"Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance","volume":"127","author":"Rajkumar","year":"2004","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib50","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib51","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","article-title":"Smoldering multiple myeloma","volume":"302","author":"Kyle","year":"1980","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.036_bib52","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0025-6196(12)65066-6","article-title":"Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies","volume":"62","author":"Greipp","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CLM.2005.n.036_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.1994.tb04908.x","article-title":"Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma","volume":"87","author":"Witzig","year":"1994","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib54","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/00007632-199711010-00017","article-title":"Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma. The GRI Study Group","volume":"22","author":"Bellaiche","year":"1997","journal-title":"Spine"},{"key":"10.3816\/CLM.2005.n.036_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0609.1997.tb00932.x","article-title":"Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens","volume":"58","author":"Vejlgaard","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib56","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1158\/1078-0432.CCR-04-1899","article-title":"Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?","volume":"11","author":"Gobbi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2005.n.036_bib57","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.036_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3816\/CLM.2005.n.013","article-title":"Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies","volume":"5","author":"Morra","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLM.2005.n.036_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3816\/CLM.2005.n.012","article-title":"Clinical characteristics and outcome of immunoglobulin M-related disorders","volume":"5","author":"Cesana","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLM.2005.n.036_bib60","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","article-title":"The clinical aspects of biclonal gammopathies. Review of 57 cases","volume":"71","author":"Kyle","year":"1981","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-198605000-00001","article-title":"The double gammopathies. Clinical and immunological studies","volume":"65","author":"Riddell","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.3816\/CLM.2005.n.036_bib62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0248-8663(97)80618-2","article-title":"Triclonal gammopathy and malignant immunoproliferative syndrome","volume":"18","author":"Grosbois","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.3816\/CLM.2005.n.036_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9343(73)90172-1","article-title":"Idiopathic Bence Jones proteinuria\u2013a distinct entity?","volume":"55","author":"Kyle","year":"1973","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM198203113061002","article-title":"\u201cIdiopathic\u00e6\u201d Bence Jones proteinuria: long-term follow-up in seven patients","volume":"306","author":"Kyle","year":"1982","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.036_bib65","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1097-0142(19910801)68:3<611::AID-CNCR2820680328>3.0.CO;2-5","article-title":"Immunoglobulin D benign monoclonal gammopathy. A case report","volume":"68","author":"O'Connor","year":"1991","journal-title":"Cancer"},{"key":"10.3816\/CLM.2005.n.036_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2141.1994.tb05037.x","article-title":"IgD monoclonal gammopathy with long-term followup","volume":"88","author":"Blade","year":"1994","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.036_bib67","series-title":"Myeloma: Biology and Management","first-page":"315","article-title":"Monoclonal gammopathies of undetermined significance","author":"Kyle","year":"2004"},{"key":"10.3816\/CLM.2005.n.036_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(57)90197-3","article-title":"Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins","volume":"23","author":"Azar","year":"1957","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jama.1960.03030030025005","article-title":"Diagnostic criteria for electrophoretic patterns of serum and urinary proteins in multiple myeloma. Study of one hundred and sixtyfive multiple myeloma patients and of seventy- seven nonmyeloma patients with similar electrophoretic patterns","volume":"174","author":"Kyle","year":"1960","journal-title":"JAMA"},{"key":"10.3816\/CLM.2005.n.036_bib70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.1975.00330010064009","article-title":"Monoclonal gammopathy in lymphoma","volume":"135","author":"Alexanian","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2005.n.036_bib71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1309\/2A0FL1HM5PN2510P","article-title":"Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients","volume":"123","author":"Lin","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2005.n.036_bib72","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.20157","article-title":"Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement","volume":"77","author":"Asatiani","year":"2004","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2005.n.036_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/87.3.385","article-title":"Monoclonal proteins in chronic lymphocytic leukemia","volume":"87","author":"Noel","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2005.n.036_bib74","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1309\/FDGWB5C2MYRYXH2E","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma associated with IgM paraprotein","volume":"123","author":"Yin","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2005.n.036_bib75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1297-319X(01)00343-8","article-title":"Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review","volume":"69","author":"Lamboley","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.3816\/CLM.2005.n.036_bib76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.1780120603","article-title":"Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia","volume":"12","author":"Zawadzki","year":"1969","journal-title":"Arthritis Rheum"},{"key":"10.3816\/CLM.2005.n.036_bib77","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.3816\/CLM.2005.n.036_bib78","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/jcp.33.7.617","article-title":"Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins","volume":"33","author":"Kahn","year":"1980","journal-title":"J Clin Pathol"},{"key":"10.3816\/CLM.2005.n.036_bib79","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199805283382207","article-title":"Neuropathies associated with paraproteinemia","volume":"338","author":"Ropper","year":"1998","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.036_bib80","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","article-title":"Autoantibodies associated with peripheral neuropathy","volume":"22","author":"Quarles","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.3816\/CLM.2005.n.036_bib81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3816\/CLM.2005.n.036_bib82","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1212\/WNL.43.11.2202","article-title":"Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy","volume":"43","author":"Simmons","year":"1993","journal-title":"Neurology"},{"key":"10.3816\/CLM.2005.n.036_bib83","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mus.20184","article-title":"Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study","volume":"31","author":"Ammendola","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.3816\/CLM.2005.n.036_bib84","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.036_bib85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/039139889902200109","article-title":"Plasma-exchange in chronic peripheral neurological disorders","volume":"22","author":"Mazzi","year":"1999","journal-title":"Int J Artif Organs"},{"key":"10.3816\/CLM.2005.n.036_bib86","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.40.4.595","article-title":"Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes","volume":"40","author":"Younger","year":"1990","journal-title":"Neurology"},{"key":"10.3816\/CLM.2005.n.036_bib87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00005792-199911000-00002","article-title":"Oligo-\/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients","volume":"78","author":"Sadighi Akha","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.3816\/CLM.2005.n.036_bib88","first-page":"153","article-title":"Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus)","volume":"2","author":"James","year":"1967","journal-title":"Clin Exp Immunol"},{"key":"10.3816\/CLM.2005.n.036_bib89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1983.tb03553.x","article-title":"Discoid lupus erythematosus and monoclonal gammopathy","volume":"109","author":"Powell","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2005.n.036_bib90","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005792-198611000-00003","article-title":"Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases","volume":"65","author":"Finan","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.3816\/CLM.2005.n.036_bib91","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0190-9622(99)70434-2","article-title":"Monoclonal gammopathies and associated skin disorders","volume":"40","author":"Daoud","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2005.n.036_bib92","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcp\/77.5.619","article-title":"Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance","volume":"77","author":"Mundis","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2005.n.036_bib93","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archinte.162.4.464","article-title":"Prevalence of monoclonal gammopathy in patients with primary hyperparathyroidism: a prospective study","volume":"162","author":"Arnulf","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2005.n.036_bib94","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500020508","article-title":"Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder","volume":"2","author":"Badley","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.3816\/CLM.2005.n.036_bib95","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0041-1345(00)02602-6","article-title":"Monoclonal gammopathy in heart transplantation: risk factor analysis and relevance of immunosup pressive load","volume":"33","author":"Caforio","year":"2001","journal-title":"Transplant Proc"},{"key":"10.3816\/CLM.2005.n.036_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000168712","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients","volume":"14","author":"Rostaing","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.3816\/CLM.2005.n.036_bib97","first-page":"350","article-title":"Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias","volume":"13","author":"Merlini","year":"1986","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2005.n.036_bib98","first-page":"572","article-title":"Artifactual hypercalcemia in multiple myeloma","volume":"57","author":"Annesley","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CLM.2005.n.036_bib99","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-197907000-00004","article-title":"Acquired C1 esterase inhibitor deficiency and angioedema: a review","volume":"58","author":"Gelfand","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.3816\/CLM.2005.n.036_bib100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fremeaux-Bacchi","year":"2002","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib101","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9343(92)90749-2","article-title":"Control of systemic capillary leak syndrome with aminophylline and terbutaline","volume":"92","author":"Droder","year":"1992","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2005.n.036_bib102","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archinte.161.6.864","article-title":"Monoclonal gammopathy of undetermined significance and exposure to breast implants","volume":"161","author":"Karlson","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2005.n.036_bib103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0002-9394(89)90225-0","article-title":"Incidence of corneal crystals in the monoclonal gammopathies","volume":"107","author":"Bourne","year":"1989","journal-title":"Am J Ophthalmol"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:49:21Z","timestamp":1631778561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011703778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1557919011703778"],"URL":"https:\/\/doi.org\/10.3816\/clm.2005.n.036","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}